Barron’s screened for energy companies in the S&P 1500 where analysts have increased their full-year earnings estimates over the past month.

Pfizer and McCormick have continued to fall in 2023 after big losses in 2022. Meanwhile, United Rentals and Nucor have continued their rallies.

Cigna, Regeneron, Centene, and six other healthcare stocks have seen short interest drop by at least 40% recently. Fewer investors are betting against them.

For Valentine's Day, Barron's looked for stocks that Wall Street loves and that look to have solid upside based on analyst price targets.

Baker Hughes, Schlumberger, Halliburton, Targa Resources, and EQT all should boost profits handily this year.

Rising interest rates, supply chain problems, inflation, and and a slowing global economy have punished car-related shares.

Utilities have been one of the top-performing sectors in the S&P 500, returning nearly 5% over the12-month period ended Jan. 6., including dividends.

Barron's looks at the most loved growth and value stocks among Wall Street analysts.

Barron's screened the Health Care Select Sector SDPR fund for healthcare stocks that have room to grow.

Higher rates are attracting more individual investors to the preferred stock market, and REITS are a relatively small subset.

Companies using strong free cash flow to pay down debt are an alternative to stocks with low valuations or where management is trying to shake up underperforming assets.

We screened for companies resistant to inflation, recession, and rate hikes. We came up with names ranging from Microsoft to Moody’s.

EV stocks have been hammered so far in 2022. Headed into the new year, are any of the shares truly buys?

At the end of 2021, with oil prices pressured, only Chevron, EQT, Par Pacific, Devon, and Dorian LPG saw shares rise.

Zoetis and Medtronic are among the healthcare stocks with the most room to rise, according to Wall Street analysts' average price targets.